Clinical Trials Directory

Trials / Completed

CompletedNCT00248885

Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)

Peri-Operative Morbidity and Quality of Life After CABG

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
248 (actual)
Sponsor
Weill Medical College of Cornell University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

It is the long term objective of this study to preserve or improve the quality of life and to prevent deterioration in physical and mental function following myocardial revascularization among bypass surgery patients.

Detailed description

The objective of this study is to compare the efficacy of two strategies of intra-operative hemodynamic management in preventing peri-operative cardiac, cognitive and neurologic morbidity and mortality and postoperative deterioration in the patient's quality of life.

Conditions

Interventions

TypeNameDescription
PROCEDURERegulating Mean Arterial Pressure during cardiopulmonary bypassPatients were randomized to one of two groups. In the first group (Low) the goal was to maintain MAP between 50-60 mm Hg during CPB. In the second group (High), the goal was to maintain MAP between 80-100 mm Hg. In both groups, CPB flow was held constant at 1.6 L/min/M2 (cool) and 2.4 L/min/M2 (warm) and vasoactive drugs (nitroglycerin or phenylephrine) were used to maintain MAP in the desired range. MAP was controlled in this fashion from the onset of CPB through separation from CPB began.

Timeline

Start date
1991-09-01
Completion
1994-09-01
First posted
2005-11-04
Last updated
2008-04-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00248885. Inclusion in this directory is not an endorsement.

Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG) (NCT00248885) · Clinical Trials Directory